Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Consort Medical PLC

+ Add to Watchlist

CSRMY:US

14.0500 USD 0.1125 0.81%

As of 21:10:06 ET on 03/04/2015.

Snapshot for Consort Medical PLC (CSRMY)

Open: 14.0500 Day's Range: 14.0500 - 14.0500 Volume: 333
Previous Close: 13.9375 52wk Range: 12.3500 - 16.1500 1-Yr Rtn: -

Stock Chart for CSRMY

No chart data available.
  • CSRMY:US 14.0500
  • 1D
  • 1M
  • 1Y
13.9375
Interactive CSRMY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSRMY

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) 19.2785
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (04/2015) 0.4910
Est. PEG Ratio -
Market Cap (M USD) 689.47
Shares Outstanding (M) 49.07
30 Day Average Volume 56
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.41%
Cash Dividend (USD) 0.0870
Dividend Ex-Date 01/14/2015
5 Year Dividend Growth 42.40%
Next Earnings Announcement 06/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSRMY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for CSRMY

Consort Medical PLC supplies drug delivery devices and development services to pharmaceutical companies. The Company develops and manufactures metered dose inhaler valves actuators, compliance-aids, dry powder devices, disposable face masks, breathing circuits and laryngeal tubes.

Jonathan GlennChief Executive OfficerRichard CottonFinance Director/Secretary
Lisa KingDirector:Human ResourcesIain WardSecretary/General Counsel
More Company Profile & Key Executives for CSRMY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil